We have covered the rising costs of medications in previous blog posts (at length), often times regarding specific medications that—while being life-changing—only affects a relatively small population. Despite the smaller personal impact of these raising prices, we address them because they are indicative of a much larger issue. The issue comes into clearer focus when a life-saving auto-injection device that is necessary to survive allergic reactions for as many as 15 million Americans raises its price by over 500%.
EpiPen has become synonymous with epinephrine auto-injectors used by those with severe allergic reactions. In 2007 a two-pack of EpiPens cost $56. Today, the same two-pack is now $365. The device itself contains about $1 worth of epinephrine.
Last year, a generic medication for toxoplasmosis—a parasitic infection that often targets individuals with weakened immune systems such as those with AIDS or cancer—increased from $13.50 per pill to $750 per pill. Despite relatively low prescription